Motiv8 Investments’s CME Group CME Stock Holding History

Motiv8 Investments’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2	Buy	+9	New	+$2.45K	﹤0.01%	735

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Motiv8 Investments's CME Position: Q4 2025 in Review

Motiv8 Investments opened a new position in CME Group (CME) in Q4 2025: 9 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #735 among its holdings.

1,732 funds tracked by Wall St. Rank hold CME as of Q4 2025.

Motiv8 Investments held 9 shares of CME Group worth $2 as of Q4 2025.
CME Group was a new Motiv8 Investments position in Q4 2025.
CME Group made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #735 holding.
1,732 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.